Denali Ventures

Fanplayr is a prominent provider of online behavioral personalization and artificial intelligence, focused on enhancing user privacy while helping businesses improve conversion rates and revenue. Headquartered in Palo Alto, California, with additional offices worldwide, Fanplayr offers a data analytics platform that delivers real-time customer insights. This platform enables businesses to implement targeted marketing strategies, collect leads, and retarget visitors with personalized recommendations both during and after the shopping experience. By leveraging analytic insights, Fanplayr assists companies in creating engaging marketing campaigns that significantly boost conversion rates and have a substantial impact on their bottom line.

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for patients with blood cancers and serious hematologic diseases. The company's lead product candidate, omidubicel, is an advanced therapy utilizing nicotinamide-expanded hematopoietic stem cells, currently undergoing Phase 3 trials for patients with high-risk hematologic malignancies and a Phase 1/2 trial for severe aplastic anemia. Additionally, Gamida Cell is advancing GDA-201, a natural killer cell-based immunotherapy that is in Phase 1/2 studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Founded in 1998 and headquartered in Jerusalem, Israel, the company employs a proprietary expansion platform that enhances the properties of nicotinamide to optimize allogeneic cell sources, including umbilical cord blood-derived cells.

Gamida Cell is a clinical-stage biopharmaceutical company focused on developing innovative cell therapies for patients with blood cancers and serious hematologic diseases. The company's lead product candidate, omidubicel, is an advanced therapy utilizing nicotinamide-expanded hematopoietic stem cells, currently undergoing Phase 3 trials for patients with high-risk hematologic malignancies and a Phase 1/2 trial for severe aplastic anemia. Additionally, Gamida Cell is advancing GDA-201, a natural killer cell-based immunotherapy that is in Phase 1/2 studies for the treatment of relapsed or refractory non-Hodgkin lymphoma and multiple myeloma. Founded in 1998 and headquartered in Jerusalem, Israel, the company employs a proprietary expansion platform that enhances the properties of nicotinamide to optimize allogeneic cell sources, including umbilical cord blood-derived cells.

HyperRoll is a provider of data warehouse performance acceleration software, specializing in its Data Performance Management Suite. This suite enhances load times, query times, and throughput for data warehouses, enabling organizations to respond swiftly to changes in data and metadata while reducing overall costs. HyperRoll's innovative software architecture represents a significant advancement in managing business data performance. In addition to its core software offerings, the company also provides solutions across various sectors, including consumer products, retail, finance, supply chain, and customer relationship management. Furthermore, HyperRoll offers advisory, consulting, education, and technical support services to assist clients in maximizing the benefits of their data management strategies.

D-Pharm (TASE: DPRM) is a drug-development company focused on innovative drugs for the treatment of central nervous system (CNS) conditions. The Company’s particular area of interest is in developing innovative medicine for degenerative and age-related disorders.

HyperRoll is a provider of data warehouse performance acceleration software, specializing in its Data Performance Management Suite. This suite enhances load times, query times, and throughput for data warehouses, enabling organizations to respond swiftly to changes in data and metadata while reducing overall costs. HyperRoll's innovative software architecture represents a significant advancement in managing business data performance. In addition to its core software offerings, the company also provides solutions across various sectors, including consumer products, retail, finance, supply chain, and customer relationship management. Furthermore, HyperRoll offers advisory, consulting, education, and technical support services to assist clients in maximizing the benefits of their data management strategies.